Companies: 10,795·Total market cap: $144.5T

Orchard Therapeutics plc

Orchard Therapeutics plc

ORTXNASDAQHealthcare

$16.70

+$0.05(+0.30%)

Market Cap$380108700

P/E Ratio—

52W High$16.72

52W Low$4.24

Avg Volume93K

Open$16.65

Beta0.55

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Orchard Therapeutics plc（ORTX）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · ORTX · 截至 Jun 9, 2026

关键指标

EPS (TTM)$7.09Earnings history

PE Ratio (TTM)2.4×PE Ratio deep dive

Revenue (TTM)$21.8MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding12.8MShares outstanding history

Next EarningsTBAEarnings history

探索 Orchard Therapeutics plc 数据

分析师预测$— · Buy

股息不分红

营收$7.0M+1346.38%

盈利EPS $-0.61+79.18%

财务快照

FY 2022Revenue$7.0M▲ +1346.38% YoY

202020212022

FY 2022Net Income-$7.9M▲ +78.31% YoY

202020212022

FY 2022EPS$-0.61▲ +79.18% YoY

202020212022

TTM:Revenue: $21.8MNet Income: $69.9MEPS: $7.09View income statement →

分析师评级与目标价

Buy10 位分析师

Strong Buy

0

Buy

6

Hold

3

Sell

1

Strong Sell

0

12-Month Price Target

$—Low

$16.70Current

$—Avg Target

$—High

合计: 10 · 买入占比: 60.0%

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Orchard Therapeutics plc

$16.70+0.30%$380.1M #2

Checkpoint Therapeutics, Inc.

$4.26+0.00%$367.7M #3

Climb Bio, Inc.

$10.77+2.09%$734.3M #4

Claritev Corporation

$27.07+4.76%$461.5M #5

G1 Therapeutics, Inc.

$7.16+0.14%$377.7M #6

iTeos Therapeutics, Inc.

$10.15+0.20%$448.7M

股票表现

1D+0.00%

1W+0.00%

1M+0.30%

3M+2.83%

YTD+1.71%

1Y+203.64%

5Y-89.42%

关于 Orchard Therapeutics plc

CEOHubert Baburaj Gaspar

IPO DateOct 31, 2018

Employees166

CountryGB

Websiteorchard-tx.com

Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and …

Biotechnology HealthcareNASDAQADRGB

关于股票概览与关键数据

Orchard Therapeutics plc（ORTX）是 Biotechnology 行业的 Healthcare 类公司，于 Oct 31, 2018 在 NASDAQ 上市。截至最近交易日，ORTX 股价为 $16.70，市值约为 $380.1M。过去12个月累计回报 +203.64%，年初至今回报 +1.71%。

根据 10 位华尔街分析师，Orchard Therapeutics plc 股票共识评级为Buy，12个月平均目标价为 $—。2022 财年 Orchard Therapeutics plc 营收 $7.0M，净利润 -$7.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Orchard Therapeutics plc（ORTX）股价为 $16.70，在 NASDAQ 上市，52周区间为 $4.24 – $16.72。

ORTX 最新股价ORTX quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议